Is it time to change the neurofibromatosis 1 diagnostic criteria?

European Journal of Internal Medicine

Volumn 25, Issue 6, 2014, Pages 506-510

  Tadini, Gianluca ^a   Milani, Donatella ^a   Menni, Francesca ^a   Pezzani, Lidia ^a   Sabatini, Caterina ^a   Esposito, Susanna ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Diagnostic criteria; Neurocutaneous disease; Neurofibromatosis 1; NF1; Rare disease

Indexed keywords

BONE MALFORMATION; CHOROID TUMOR; CHOROIDAL HAMARTOMA; CLINICAL FEATURE; ENDOCRINE SYSTEM; GENETIC ANALYSIS; GENOTYPE; HUMAN; NATIONAL HEALTH ORGANIZATION; NEUROFIBROMATOSIS; NEVUS; NEVUS ANEMICUS; OPTIC NERVE GLIOMA; PEDIATRICS; PHAKOMATOSIS; PHENOTYPE; PROGNOSIS; REVIEW; SKIN MANIFESTATION; VASCULAR DISEASE; BONE DISEASES; COMPLICATION; GENETICS; HAMARTOMA; HYPERTELORISM; IRIS DISEASES; LEARNING DISORDERS; NEUROFIBROMATOSIS 1; SPEECH DISORDERS; TUMOR SUPPRESSOR GENE;

BONE DISEASES; GENES, NEUROFIBROMATOSIS 1; HAMARTOMA; HUMANS; HYPERTELORISM; IRIS DISEASES; LEARNING DISORDERS; NEUROFIBROMATOSIS 1; OPTIC NERVE GLIOMA; SPEECH DISORDERS;

EID: 84903378888     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2014.04.004     Document Type: Review

References (57)

1. National Institutes of Health Consensus Development Conference Statement Neurofibromatosis Arch Neurol (Chic) 45 1988 575 578
2. A. Sabbagh, E. Pasmant, A. Imbard, A. Luscan, M. Soares, and H. Blanché et al. NF1 molecular characterization and neurofibromatosis type 1 genotype-phenotype correlation: the French experience Hum Mutat 34 2013 1510 1518
3. D. Viskochil, A.M. Buchberg, G. Xu, R.M. Cawthon, J. Stevens, and R.K. Wolff et al. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus Cell 62 1990 187 192
4. A.B. Trovó-Marqui, and E.H. Tajara Neurofibromin: a general outlook Clin Genet 70 2006 1 13
5. E. Pasmant, A. Sabbagh, G. Spurlock, I. Laurendeau, E. Grillo, and M.J. Hamel et al. NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype Hum Mutat 31 2010 1506 1518
6. M. Upadhyaya, S.M. Huson, M. Davies, N. Thomas, N. Chuzhanova, and S. Giovannini et al. An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation Am J Hum Genet 80 2007 140 151
7. E.M. Burkitt Wright, E. Sach, S. Sharif, O. Quarrell, T. Carroll, and R.W. Whitehouse et al. Can the diagnosis of NF1 be excluded clinically? A lack of pigmentary findings in families with spinal neurofibromatosis demonstrates a limitation of clinical diagnosis J Med Genet 50 2013 606 613
8. K. DeBella, J. Szudek, and J.M. Friedman Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children Pediatrics 105 2000 608 614
9. T.A. Duong, S. Bastuji-Garin, L. Valeyrie-Allanore, E. Sbidian, S. Ferkal, and P. Wolkenstein Evolving pattern with age of cutaneous signs in neurofibromatosis type 1: a cross-sectional study of 728 patients Dermatology 222 2011 269 273
10. E.M. Jouhilahti, S. Peltonen, A.M. Heape, and J. Peltonen The pathoetiology of neurofibromatosis 1 Am J Pathol 178 2011 1932 1939
11. A. Overdiek, U. Winner, E. Mayatepek, and T. Rosenbaum Schwann cells from human neurofibromas show increased proliferation rates under the influence of progesterone Pediatr Res 64 2008 40 43
12. O. Abbas, and J. Bhawan Cutaneous plexiform lesions J Cutan Pathol 37 2010 613 623
13. K.P. Boyd, B.R. Korf, and A. Theos Neurofibromatosis type 1 J Am Acad Dermatol 61 2009 1 14
14. S. Cambiaghi, L. Restano, and R. Caputo Juvenile xanthogranuloma associated with neurofibromatosis 1: 14 patients without evidence of hematologic malignancies Pediatr Dermatol 21 2004 97 101
15. M. Raygada, D.C. Arthur, A.S. Wayne, O.M. Rennert, J.A. Toretsky, and C.A. Stratakis Juvenile xanthogranuloma in a child with previously unsuspected neurofibromatosis type 1 and juvenile myelomonocytic leukemia Pediatr Blood Cancer 54 2010 173 175
16. J. Zeller, J. Wechsler, J. Revuz, and P. Wolkenstein Blue-red macules and pseudoatrophic macules in neurofibromatosis 1 Ann Dermatol Venereol 129 2002 180 181
17. F.C. Yang, S. Chen, T. Clegg, X. Li, T. Morgan, and S.A. Estwick et al. Nf1 +/- mast cells induce neurofibroma like phenotypes through secreted TGF-β signaling Hum Mol Genet 15 2006 2421 2437
18. H. Brems, C. Park, O. Maertens, A. Pemov, L. Messiaen, and M. Upadhyaya et al. Glomus tumors in neurofibromatosis type 1: genetic, functional and clinical evidence of a novel association Cancer Res 69 2009 7393 7401
19. G. Tadini, M. Brena, L. Pezzani, C. Gelmetti, F. Santagada, and M.P. Boldrini Anemic nevus in neurofibromatosis type 1 Dermatology 226 2013 115 118
20. N.K. Ragge, R.E. Falk, W.E. Cohen, and A.L. Murphree Images of Lisch nodules across the spectrum Eye (Lond) 7 1993 95 101
21. T.H. Williamson, A. Garner, and A.T. Moore Structure of Lisch nodules in neurofibromatosis type 1 Ophthalmic Paediatr Genet 12 1991 11 17
22. F. Viola, E. Villani, F. Natacci, A. Selicorni, G. Melloni, and D. Vezzola et al. Choroidal abnormalities detected by near-infrared reflectance imaging as a new diagnostic criterion for neurofibromatosis 1 Ophthalmology 119 2012 369 375
23. R.A. Avery, M.J. Fisher, and G.T. Liu Optic pathway gliomas J Neuroophthalmol 31 2011 269 278
24. R. Listernick, R.E. Ferner, G.T. Liu, and D.H. Gutmann Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations Ann Neurol 61 2007 189 198
25. R.A. Avery, R.E. Ferner, R. Listernick, M.J. Fisher, D.H. Gutmann, and G.T. Liu Visual acuity in children with low grade gliomas of the visual pathway: implications for patient care and clinical research J Neurooncol 110 2012 1 7
26. C. Cassiman, E. Legius, W. Spileers, and I. Casteels Ophthalmological assessment of children with neurofibromatosis type 1 Eur J Pediatr 172 2013 1327 1333
27. L. Armstrong, K. Jett, P. Birch, D.L. Kendler, H. McKay, and E. Tsang et al. The generalized bone phenotype in children with neurofibromatosis 1: a sibling matched case-control study Am J Med Genet A 161 2013 1654 1661
28. D.K. Arrington, A.R. Danehy, A. Peleggi, M.R. Proctor, M.B. Irons, and N.J. Ullrich Calvarial defects and skeletal dysplasia in patients with neurofibromatosis type 1 J Neurosurg Pediatr 11 2013 410 416
29. D. Carmi, M. Shohat, A. Metzker, and Z. Dickerman Growth, puberty, and endocrine functions in patients with sporadic or familial neurofibromatosis type 1: a longitudinal study Pediatrics 103 1999 1257 1262
30. X. Sheng, J.C. Carey, B. Dube, and D.H. Viskochil Bone mineral density in children and adolescents with neurofibromatosis type 1 J Pediatr 150 2007 83 88
31. D.A. Stevenson, D.H. Viskochil, J.C. Carey, X. Sheng, M. Murray, and L. Moyer-Mileur et al. Pediatric 25-hydroxyvitamin D concentrations in neurofibromatosis type 1 J Pediatr Endocrinol Metab 24 2011 169 174
32. C.W. Hockett, J. Eelloo, S.M. Huson, S.A. Roberts, J.L. Berry, and C. Chaloner Vitamin D status and muscle function in children with neurofibromatosis type 1 (NF1) J Musculoskelet Neuronal Interact 13 2013 111 119
33. A.E. Lin, P.H. Birch, B.R. Korf, R. Tenconi, M. Niimura, and M. Poyhonen et al. Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1 Am J Med Genet 95 2000 108 117
34. G.S. Oderich, T.M. Sullivan, T.C. Bower, P. Gloviczki, D.V. Miller, and D. Babovic-Vuksanovic et al. Vascular abnormalities in patients with neurofibromatosis syndrome type I: clinical spectrum, management, and results J Vasc Surg 46 2007 475 484
35. M. Han, and E. Criado Renal artery stenosis and aneurysms associated with neurofibromatosis J Vasc Surg 41 2005 539 543
36. P.N. Margariti, K. Blekas, F.G. Katzioti, A.K. Zikou, M. Tzoufi, and M.I. Argyropoulou Magnetization transfer ratio and volumetric analysis of the brain in macrocephalic patients with neurofibromatosis type 1 Eur Radiol 17 2007 433 438
37. R.G. Steen, J.S. Taylor, J.W. Langston, J.O. Glass, V.R. Brewer, and W.E. Reddick et al. Prospective evaluation of the brain in asymptomatic children with neurofibromatosis type 1: relationship of macrocephaly to T1 relaxation changes and structural brain abnormalities Am J Neuroradiol 22 2001 810 817
38. D.H. Gutmann, L.F. Parada, A.J. Silva, and N. Ratner Neurofibromatosis type 1: modeling CNS dysfunction J Neurosci 32 2012 14087 14093
39. K. DeBella, K. Poskitt, J. Szudek, and J.M. Friedman Use of "unidentified bright objects" on MRI for diagnosis of neurofibromatosis 1 in children Neurology 54 2000 1646 1650
40. S.L. Hervey-Jumper, N. Singla, S.S. Gebarski, P. Robertson, and C.O. Maher Diffuse pontine lesions in children with neurofibromatosis type 1: making a case for unidentified bright objects Pediatr Neurosurg 49 2013 55 59
41. A.P. Ostendorf, D.H. Gutmann, and J.L.Z. Weisenberg Epilepsy in individuals with neurofibromatosis type 1 Epilepsia 54 2013 1810 1814
42. H.Y. Hsieh, H.C. Fung, C.J. Wang, S.C. Chin, and T. Wu Epileptic seizures in neurofibromatosis type 1 are related to intracranial tumors but not to neurofibromatosis bright objects Seizure 20 2011 606 611
43. A. Créange, J. Zeller, S. Rostaing-Rigattieri, P. Brugières, J.D. Degos, and J. Revuz et al. Neurological complications of neurofibromatosis type 1 in adulthood Brain 122 1999 473 481
44. M. Carotenuto, and M. Esposito Nutraceuticals safety and efficacy in migraine without aura in a population of children affected by neurofibromatosis type 1 Neurol Sci 34 2013 1905 1909
45. S.L. Hyman, E.A. Shores, and K.N. North The nature and frequency of cognitive deficits in children with neurofibromatosis type 1 Neurology 65 2005 1037 1044
46. A. Lehtonen, E. Howi, D. Trump, and S.M. Huson Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competence Dev Med Child Neurol 55 2013 111 125
47. C.V. Dilts, J.C. Carey, J.C. Kircher, R.O. Hoffman, D. Creel, and K. Ward et al. Children and adolescents with neurofibromatosis 1: a behavioral phenotype J Dev Behav Pediatr 17 1996 229 239
48. L.C. Krab, F.K. Aarsen, A. de Goede-Bolder, C.E. Catsman-Berrevoets, W.F. Arts, and H.A. Moll et al. Impact of neurofibromatosis type 1 on school performance J Child Neurol 23 2008 1002 1010
49. S. Garg, J. Green, K. Leadbitter, R. Emsley, A. Lehtonen, and D.G. Evans et al. Neurofibromatosis type 1 and autism spectrum disorder Pediatrics 132 2013 1642 1648
50. S. Patil, and R.S. Chamberlain Neoplasms associated with germline and somatic NF1 gene mutations Oncologist 17 2012 101 116
51. O.O. Seminog, and M.J. Goldacre Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study Br J Cancer 108 2013 193 198
52. A. Van Lierde, F. Menni, M.F. Bedeschi, F. Natacci, S. Guez, and P. Vizziello et al. Healthcare transition in patients with rare genetic disorders with and without developmental disability: neurofibromatosis 1 and Williams-Beuren syndrome Am J Med Genet A 161A 2013 1666 1674
53. W. Lamm, S. Schur, W.J. Köstler, P. Funovics, R. Windhager, and G. Amann et al. Clinical signs of neurofibromatosis impact on the outcome of malignant peripheral nerve sheath tumors Oncology 86 2014 122 126
54. S. Granstrom, A. Langenbruch, M. Augustin, and V.F. Mautner Psychological burden in adult neurofibromatosis type 1 patients: impact of disease visibility on body image Dermatology 224 2012 160 167
55. V.L. Merker, M.A. Bredella, W. Cai, A. Kassarjian, G.J. Harris, and A. Muzikansky et al. Relationship between whole-body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis Am J Med Genet A 2014 10.1002/ajmg.a.36466 [Epub Mar 24]
56. D.G. Evans, C. O'Hara, A. Wilding, S.L. Ingham, E. Howard, and J. Dawson et al. Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989 Eur J Hum Genet 19 2011 1187 1191
57. B.C. Widemann, M.T. Acosta, S. Ammoun, A.J. Belzberg, A. Bernards, and J. Blakeley et al. CTF meeting 2012: translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies Am J Med Genet A 164 2014 563 578